Stansberry Asset Management’s AbbVie ABBV Stock Holding History

Stansberry Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Buy	1,747 +79	+5%	+$17K	0.04%	128
2026 Q1	$363K	Sell	1,668 -236	-12%	-$52.4K	0.04%	129
2025 Q4	$435K	Buy	1,904 +123	+7%	+$28K	0.04%	133
2025 Q3	$412K	Hold	1,781	–	–	0.04%	134
2025 Q2	$331K	Sell	1,781 -49	-3%	-$9.11K	0.04%	134
2025 Q1	$383K	Sell	1,830 -150	-8%	-$29.2K	0.05%	119
2024 Q4	$352K	Buy	+1,980	New	+$364K	0.05%	118
2018 Q2	–	Sell	-22,268	Closed	-$2.11M	–	96
2018 Q1	$2.11M	Buy	+22,268	New	+$2.45M	1.03%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stansberry Asset Management's ABBV Position: Q2 2026 in Review

Stansberry Asset Management increased its AbbVie (ABBV) stake by 4.7% in Q2 2026, buying an estimated $17K and bringing the position to 1,747 shares worth $440K. The position accounts for 0.04% of the portfolio, ranked #128.

Stansberry Asset Management first reported a position in ABBV in Q1 2018 and has held it in 8 quarters since. The position peaked at $2.11M in Q1 2018. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stansberry Asset Management held 1,747 shares of AbbVie worth $440K as of Q2 2026.
Stansberry Asset Management bought 79 AbbVie shares in Q2 2026, an estimated $17K.
AbbVie made up 0.04% of Stansberry Asset Management's portfolio in Q2 2026, its #128 holding.
Stansberry Asset Management first reported a position in AbbVie in Q1 2018 and has held it in 8 quarters since.
Stansberry Asset Management's AbbVie position peaked at $2.11M in Q1 2018.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stansberry Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.